Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Malignant Pleural Effusion Market Size From 2025 to 2034?

In recent years, the market size for malignant pleural effusion has seen significant growth. The expectation is for the market to further expand from $4.42 billion in 2024 to $4.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historical period include the burgeoning use of indwelling pleural catheters, a heightened emphasis on palliative care, an increase in clinical trials, a rise in reimbursement, and an escalation in metastatic malignancies.

Expectations are high for significant expansion in the malignant pleural effusion market in the upcoming years. The market is projected to reach a value of$6.12 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This potential growth during the forecasted period is attributable to several factors such as the development of healthcare facilities, enhanced government backing, a rise in cancer survival rates, an increased demand for care within the home, and growth in the sector of liquid biopsy. Throughout the forecast period, major tendencies will include the incorporation of AI into imaging instruments, advancements in therapies specifically targeting cancer, progression in pleurodesis, enhancements in biomarkers, and a wider range of clinical trials for new therapeutic agents.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22047&type=smp

What Are the Core Market Drivers Propelling Growth in the Malignant Pleural Effusion Industry?

The malignant pleural effusion market is anticipated to expand due to increasing instances of lung cancer. Characterized by uncontrolled growth of anomalous cells in the lungs, lung cancer can interfere with regular lung functionality and potentially form tumors. The number of lung cancer cases is augmenting mainly due to smoking and tobacco usage, as long-term exposure to hazardous substances present in cigarettes can harm lung tissues, lead to genetic alterations, and stimulate the unrestrained growth of malignant cells. This considerably heightens the risk of lung cancer and its advanced stages often indicated by malignant pleural effusion, which encourages tumor propagation within the pleural cavity and diminishes respiratory performance. According to the American Cancer Society Facts and Figures, in January 2023, new cases of lung and bronchus cancer were projected to be 236,740 in 2022 and increase to 238,340 in 2023, while an estimated 130,180 deaths in 2022 were expected to drop slightly to 127,070 in 2023. Hence, the escalation of lung cancer cases is spurring the growth of the malignant pleural effusion market.

How Is the Malignant Pleural Effusion Market Segmented?

The malignant pleural effusionmarket covered in this report is segmented –

1) By Treatment: Systemic Therapy; Therapeutic Thoracentesis; Thoracic Drainage And Pleurodesis; Indwelling Pleural Catheter

2) By Diagnosis: Pleural Fluid Cytology; Immunohistochemical Tests; Imaging Tests; Pleural Thoracentosis; Pleuroscopy; Pleural Biopsy

3) By End Users: Hospitals; Ambulatory Clinics; Other End Users

Subsegments:

1) By Systemic Therapy: Chemotherapy; Targeted Therapy; Immunotherapy

2) By Therapeutic Thoracentesis: Single-Time Thoracentesis; Repeated Thoracentesis

3) By Thoracic Drainage And Pleurodesis:Chemical Pleurodesis; Mechanical Pleurodesis; Biological Pleurodesis

4) By Indwelling Pleural Catheter:Tunneled Pleural Catheter; Non-Tunneled Pleural Catheter

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22047&type=smp

Which Regions Are Driving the Next Phase of the Malignant Pleural Effusion Market Growth?

North America was the largest region in the malignant pleural effusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant pleural effusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Malignant Pleural Effusion Industry?

Prominent companies in the malignant pleural effusion market are giving top priority to the creation of groundbreaking therapies, such as enzyme-targeting therapy. This strategy is aimed at boosting the outcomes of treatments by precisely focusing on specific enzymes responsible for fluid buildup. Enzyme-targeting therapy is a medical technique that concentrates on creating treatments or medications to particularly inhibit or alter the functioning of enzymes related to diseases. This sort of treatment is prevalently used in health conditions like cancer, metabolic irregularities, and infectious diseases where unusual enzyme activity leads to the disease worsening. For example, in September 2022, RS Oncology, LLC, an American biotechnology company, initiated the MITOPE clinical trial. This trial is a first for human Phase 1/2 trial carried out in the United Kingdom. The study is a Phase 1/2 trial which tests RSO-021, a groundbreaking PRX3 inhibitor intended to treat malignant pleural effusion and mesothelioma. It does this by focusing on oxidative stress to eradicate cancer cells but at the same time preserving healthy tissue.

View the full report here:

https://www.thebusinessresearchcompany.com/report/malignant-pleural-effusion-global-market-report

How Is the Malignant Pleural Effusion Market Defined and What Are Its Core Parameters?

Malignant pleural effusion (MPE) refers to the accumulation of fluid in the pleural space due to the presence of cancer cells, typically resulting from metastatic disease. This condition occurs when cancer spreads to the pleura, the thin membrane surrounding the lungs, leading to increased vascular permeability and impaired lymphatic drainage.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22047

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model